Modulation of angiogenesis

Details for Australian Patent Application No. 2011220940 (hide)

Owner ABT Holding Company

Inventors Woda, Juliana Megan; Ting, Anthony E.; Lehman, Nicholas A.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2011220940

PCT Pub. Number WO2011/106365

Priority 61/308,103 25.02.10 US

Filing date 23 February 2011

Wipo publication date 1 September 2011

International Classifications

C12N 5/074 Undifferentiated human, animal or plant cells, e.g. cell lines - Adult stem cells

A61P 9/00 Drugs for disorders of the cardiovascular system

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/106365 Priority application(s): WO2011/106365

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011221037-1,3,4,8-tetrahydro-2H-pyrido[1,2a]pyrazine derivative and use of same as HIV integrase inhibitor

2011220916-Device and system for determining, preparing and administering therapeutically effective doses